Arkolith/Insider Trading/CNTX/Form 4

Lehr Martin A.

Chief Executive Officer, DirectorContext Therapeutics Inc. (CNTX) · full profile →Form 4 · filed Oct 25, 2021
Net Buying
Open-Market Buys
$50K
Open-Market Sells
$0
Net Open-Market Flow
$50K
Transactions
7
4 non-derivative · 3 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Oct 22, 2021Conversion(C)211K——263K
Oct 22, 2021Buy(P)10K$5.00$50K100K
Oct 22, 2021Option exercise(O)53K$7.14$376K53K
Oct 22, 2021Conversion(C)586K——850K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Oct 22, 2021Conversion(C)211K——0
Oct 22, 2021Conversion(C)586K——0
Oct 22, 2021Option exercise(O)53K—$00

Transaction Codes

C
Conversion of a derivative
P
Open-market purchase
O
See SEC Form 4 code table

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001179110-21-009609) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML